2 April 2026

BSF Enterprise PLC

Further Investment and Appointment of Adviser

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has placed 38,500,000 new ordinary shares in the Company ("Placing Shares") raising £385,000 before expenses at 1p per share in a placing ("Placing") utilising the Company's total available headroom without further authority from shareholders.

In light of the exciting news on the unveiling of our T-Rex leather Handbag the Placing was arranged within our present headroom. This fundraise was supported by a single strategic investor to reinforce the Company's strategic business and growth plans, with the possibility of significant growth in shareholder value throughout 2026.

Appointment of Financial Adviser and Broker

BSF is pleased to announce that it has appointed Bowsprit Partners Limited ("Bowsprit Partners") as its Financial Adviser and Broker with immediate effect.

Bowsprit Partners is a London-based corporate finance and corporate broking firm specialising in advising both public and private companies. Bowsprit Partners is a Member Firm of the London Stock Exchange and holds multiple accreditations including Listing Sponsor status for the Euronext Growth and Access Markets in Paris, Brussels, Lisbon and Dublin, Euronext Growth Advisor for Euronext Growth Oslo, Corporate Adviser for the Aquis Stock Exchange, Certified Adviser for the Nasdaq First North Growth Market in Stockholm and US OTC Markets Sponsor permission for international companies.

Issue of Warrants

For every Placing Share issued pursuant to the Placing, investors will receive 1 warrant allowing the holder to subscribe for an additional Ordinary Share in the Company at an exercise price of 1.5p per Ordinary Share, exercisable within 3 years of Admission ("Investor Warrants"). In aggregate 38,500,000 Warrants have been issued pursuant to the Placing.

In connection with the Placing, the Company will issue, on completion of the Placing, 23,100 warrants to Bowsprit Partners who arranged the Placing ("Broker Warrants"). The Broker Warrants shall be exercisable at 1p per Ordinary Share. The Broker Warrants are exercisable at any time within three years of Admission.

Any issuance of shares under the Investor Warrants or Broker Warrants will be subject to available authority to issue shares being granted by the Company's shareholders in due course.

Admission

Completion of the Placing is conditional on, inter alia, the Placing Shares being admitted to listing on the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission").  

Applications will be made to the FCA and to the London Stock Exchange for Admission in respect of all the Placing Shares proposed to be issued on completion of the Placing. It is expected that Admission will become effective, and that dealings in the Placing Shares are expected to commence on or around 8.00 a.m. on or around 15 April 2026.

The rights attaching to the Placing Shares will rank pari passu with the existing ordinary shares of the Company.

Total Voting Rights

Following Admission, the Company's enlarged share capital will comprise 166,874,437 ordinary shares of 1 penny each. Therefore, the total number of voting rights in the Company will be 166,874,437. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

END

Engage with the BSF Enterprise management team directly by asking questions, watching video
summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor
website here:

https://bsfenterprise.com/link/eNwpdr

For further enquiries, please visit www.bsfenterprise.com or contact:

Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43

About BSF Enterprise PLC

BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather (via LGL), cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance alternatives to conventional materials, targeting global markets where provenance, ethics, and performance are increasingly prized by consumers and brands alike.